Richard Adams at Cardiff University - Research Interests, Publications & Academic Profile

Richard Adams

Professor

Cardiff University

United Kingdom

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Indian students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Academic Page

Research Interests

Pharmacotherapy

90%

Biostatistics

40%

Oncology

70%

Adjuvant Therapy

40%

Cancer Biology

40%

Cancer Therapy

40%

Cancer Epidemiology

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

Wales Cancer Biobank

Open Date: 2020-10-01

Close Date: 2023-09-01

Grant: Close

Wales Cancer Research Centre

Open Date: 2020-10-01

Close Date: 2023-09-01

Grant: Open

ARIEL: A biomarker enrichment trial of anti-EGFR agents in patients with advanced colorectal cancer with wild-type RAS and right primary tumour location

Open Date: 2020-10-01

Close Date: 2026-03-31

Grant: Close

VALTIVE1: validation of Tie2 as the first tumour vascular response biomarker for VEGF inhibitors

Open Date: 2020-03-01

Close Date: 2023-12-01

Grant: Close

Centre for Trials Research Cardiff - HCRW

Open Date: 2019-10-01

Close Date: 2024-09-01

Articles15

The Impact of National Radiotherapy Guidelines: The UK Anal Cancer Story

Article Link

Year:

2024

Once daily cediranib and weekly paclitaxel to prevent malignant bowel obstruction in at-risk patients with platinum-resistant ovarian cancer (CEBOC): a single-arm, phase II safety trial

Article Link

Year:

2024

Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis: the EASI-SWITCH RCT

Article Link

Year:

2024

Efficacy of immune checkpoint inhibitors for metastatic colorectal cancer with microsatellite instability in second or latter line using synthetic control arms: A non-randomised evaluation

Article Link

Year:

2024

Aspirin and cancer treatment: systematic reviews and meta-analyses of evidence: for and against

Article Link

Year:

2024

Evaluation of Intratumoral Response Heterogeneity in Metastatic Colorectal Cancer and Its Impact on Patient Overall Survival: Findings from 10,551 Patients in the ARCAD Database

Article Link

Year:

2023

Early switch to oral antibiotic therapy in patients with low risk neutropenic sepsis (EASI-SWITCH): A randomized non-inferiority trial

Article Link

Year:

2023

Efficacy of early PET-CT directed switch to carboplatin and paclitaxel based definitive chemoradiotherapy in patients with oesophageal cancer who have a poor early response to induction cisplatin and capecitabine in the UK: a multi-centre randomised controlled phase II trial

Article Link

Year:

2023

Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3,369 patients in the ARCAD database

Article Link

Year:

2023

Development of a core outcome set for use in adult primary glioma phase III interventional trials: A mixed methods study

Article Link

Year:

2023

A Road Map for Designing Phase I Clinical Trials of Radiotherapy–Novel Agent Combinations

Article Link

Year:

2022

Molecular selection of therapy in metastatic colorectal cancer: the FOCUS4 molecularly stratified RCT

Article Link

Year:

2022

Trajectories of body weight change and survival among patients with mCRC treated with systemic therapy: Pooled analysis from the ARCAD database

Article Link

Year:

2022

Experiences of running a stratified medicine adaptive platform trial: Challenges and lessons learned from 10 years of the FOCUS4 trial in metastatic colorectal cancer

Article Link

Year:

2022

Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical Trials

Article Link

Year:

2022

Collaborators16

Matthew Seymour

Professor of Gastrointestinal Cancer Medicine

University of Leeds

UNITED KINGDOM

Philip Quirke

University of Leeds

UNITED KINGDOM

David J. Fisher

UNITED KINGDOM

Emma Hall

Institute of Cancer Research

UNITED KINGDOM

Maria Andreia Hawkins

University College London

UNITED KINGDOM

John R. Zalcberg

AUSTRALIA

Ian Chau

Royal Marsden Hospital Sutton

UNITED KINGDOM

Louise Brown

University College London

UNITED KINGDOM

Samantha Hinsley

University of Glasgow

UNITED KINGDOM

Emiliano Spezi

Professor of Healthcare Engineering and Director of Research

Cardiff University

UNITED KINGDOM

Leslie Samuel

University of Aberdeen

UNITED KINGDOM

Timothy Stanley Maughan

Professor of Clinical Oncology, CRUK/MRC Oxford Institute for Radiation Oncology

University of Oxford

UNITED KINGDOM

Anthony Byrne

Cardiff University School of Medicine

UNITED KINGDOM

Chris Hurt

Cardiff University School of Medicine

UNITED KINGDOM

Anna Dorothea Wagner

Senior lecturer, consultant and head of the gastrointestinal cancer outpatient clinic

Lausanne University Hospital

SWITZERLAND

Eric Van Cutsem

BELGIUM

How do Indian students reach out?

Meet Kite AI